Global SNP Microarray Testing and Analysis Market Growth (Status and Outlook) 2025-2031

The global SNP Microarray Testing and Analysis market size is predicted to grow from US$ 1491 million in 2025 to US$ 2475 million in 2031; it is expected to grow at a CAGR of 8.8% from 2025 to 2031.

SNP microarray testing and analysis is a powerful genetic technology that plays a crucial role in modern genetics research and clinical applications. It involves the use of microarray chips densely populated with thousands to millions of probes designed to detect single nucleotide polymorphisms (SNPs), which are the most common type of genetic variation in the human genome. By hybridizing a patient's or research subject's DNA sample to the microarray, the technology can rapidly identify and genotype these SNPs across a large portion of the genome. This data can be used for a wide range of purposes. In research, it enables genome - wide association studies (GWAS) to uncover genetic loci associated with complex diseases, traits, and drug responses. In clinical settings, SNP microarray testing can assist in diagnosing genetic disorders, detecting chromosomal abnormalities, and predicting an individual's susceptibility to certain diseases. Overall, SNP microarray testing and analysis provide a comprehensive and efficient way to explore the genetic basis of various biological phenomena and improve medical understanding and patient care.

United States market for SNP Microarray Testing and Analysis is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for SNP Microarray Testing and Analysis is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for SNP Microarray Testing and Analysis is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key SNP Microarray Testing and Analysis players cover Thermo Fisher Scientific, Illumina, Agilent, Roche, Bio-Rad, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “SNP Microarray Testing and Analysis Industry Forecast” looks at past sales and reviews total world SNP Microarray Testing and Analysis sales in 2024, providing a comprehensive analysis by region and market sector of projected SNP Microarray Testing and Analysis sales for 2025 through 2031. With SNP Microarray Testing and Analysis sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world SNP Microarray Testing and Analysis industry.

This Insight Report provides a comprehensive analysis of the global SNP Microarray Testing and Analysis landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on SNP Microarray Testing and Analysis portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global SNP Microarray Testing and Analysis market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for SNP Microarray Testing and Analysis and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global SNP Microarray Testing and Analysis.

This report presents a comprehensive overview, market shares, and growth opportunities of SNP Microarray Testing and Analysis market by product type, application, key players and key regions and countries.

Segmentation by Type:
Whole Genome SNP Microarray
Customized SNP Microarray

Segmentation by Application:
Pharmaceuticals and Pharmacogenomics
Diagnostic Research
Agricultural Biotechnology
Breeding and Animal Livestock

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Thermo Fisher Scientific
Illumina
Agilent
Roche
Bio-Rad
CD Genomics
Ambry Genetics
Labcorp
Allele Diagnostics
Sonic Genetics
Invitae
Genetics Generation Advancement (GGA)
Quest Diagnostics
CapitalBio
HNL Lab Medicine
Psomagen
VCGS
Genetics Associates

Please note: The report will take approximately 2 business days to prepare and deliver. Show more